Accumulation of genetic alterations and their significance in each primary human cancer and cell line

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 400, Issue 1-2, 1998, Pages 421-437

  Murakami, Yoshinori ^a   Sekiya, Takao ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Glioma; Hepatocellular carcinoma; Non small cell lung cancer; Oncogene; Pancreatic cancer; Tumor suppressor gene

Indexed keywords

ARTICLE; DNA DETERMINATION; GENE MUTATION; GLIOMA; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LUNG NON SMALL CELL CANCER; MALIGNANT NEOPLASTIC DISEASE; ONCOGENE; PANCREAS CANCER; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

CELL DIVISION; DNA MUTATIONAL ANALYSIS; HUMANS; MUTATION; NEOPLASMS; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TUMOR CELLS, CULTURED;

EID: 0032565571     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(98)00031-1     Document Type: Article

References (101)

1. [1] R.A. Weinberg, How cancer arises, Sci. Am. 275 (1996) 62-70.
2. [2] S. Nishimura, T. Sekiya, Human cancer and cellular oncogenes, Biochem. J. 243 (1987) 313-327.
3. [3] W.K. Cavenee, R.L. White, The genetic basis of cancer, Sci. Am. 272 (1995) 72-79.
4. [4] L. Zhu, G.H. Enders, C.L. Wu, M.A. Starz, K.H. Moberg, J.A. Lees, N. Dyson, E. Harlow, Growth suppression by members of the retinoblastoma protein family, Cold Spring Harbor Symposia on Quantitative Biology 59, 1994, 75-84.
5. [5] M. Orita, H. Iwahana, H. Kanazawa, K. Hayashi, T. Sekiya, Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms, Proc. Natl. Acad. Sci. USA 86 (1989) 2766-8409.
6. [6] W. Jiang, Y.J. Zhang, S.M. Kahn, M.C. Hollstein, R.M. Santella, S.H. Lu, C.C. Harris, R. Montesano, I.B. Weinstein, Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer, Proc. Natl. Acad. Sci. USA 90 (1993) 9026-9030.
7. [7] M. Hollstein, D. Sidransky, B. Vogelstein, C.C. Harris, p53 mutations in human cancers, Science 253 (1991) 49-53.
8. [8] J.D. Oliner, K.W. Kinzler, P.S. Meltzer, D.L. George, B. Vogelstein, Amplification of a gene encoding a p53-associated protein in human sarcomas, Nature 358 (1992) 80-83.
9. [9] F.S. Leach, T. Tokino, P. Meltzer, M. Burrell, M.J.D. Oliner, S. Smith, D.E. Hill, D. Sidransky, K.W. Kinzler, B. Vogelstein, p53 mutation and MDM2 amplification in human soft tissue sarcomas, Cancer Res. 53 (1993) 2231-2234.
10. [10] W.S. el-Deiry, T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, J.M. Trent, D. Lin, W.E. Mercer, K.W. Kinzler, B. Vogelstein, WAF1, a potential mediator of p53 tumor suppression, Cell 75 (1993) 817-825.
11. [11] M.R. Smith, S.J. DeGudicibus, D.W. Stacey, Requirement for c-ras proteins during viral oncogene transformation, Nature 320 (1986) 540-543.
12. [12] M. Fukui, T. Yamamoto, S. Kawai, K. Maruo, K. Toyoshima, Detection of a raf-related and two other transforming DNA sequences in human tumors maintained in nude mice, Proc. Natl. Acad. Sci. USA 82 (1985) 5954-5958.
13. [13] F. Ishikawa, F. Takaku, K. Hayashi, M. Nagao, T. Sugimura, Activation of rat c-raf during transfection of hepatocellular carcinoma DNA, Proc. Natl. Acad. Sci. USA 83 (1986) 3209-3212.
14. [14] T.F. Franke, S.I. Yang, T.O. Chan, K. Datta, A. Kazlauskas, D.K. Morrison, D.R. Kaplan, P.N. Tsichlis, The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase, Cell 81 (1995) 727-736.
15. [15] J.Q. Cheng, B. Ruggeri, W.M. Klein, G. Sonoda, D.A. Altomare, D.K. Watson, J.R. Testa, Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA, Proc. Natl. Acad. Sci. USA 93 (1996) 3636-3641.
16. [16] W. Miwa, J. Yasuda, Y. Murakami, K. Yashima, K. Sugano, T. Sekine, A. Kono, S. Egawa, K. Yamaguchi, Y. Hayashizaki, T. Sekiya, Isolation of DNA sequences amplified at chromosome 19q13.1-q13.2 including the AKT2 locus in human pancreatic cancer, Biochem. Biophys. Res. Commun. 225 (1996) 968-974.
17. [17] V. Murray, Improved double-stranded DNA sequencing using the linear polymerase chain reaction, Nucleic Acids Res. 17 (1989) 8889.
18. [18] B.J. Conner, A.A. Reyes, C. Morin, K. Itakura, R.L. Teplitz, R.B. Wallace, Detection of sickle cell bS-globin allele by hybridization with synthetic oligonucleotides, Proc. Natl. Acad. Sci. USA 80 (1983) 278-282.
19. [19] S.S. Sommer, A.R. Groszbach, C.D. Bottema, PCR amplification of specific alleles (PASA) is a general method for rapidly detecting known single-base changes, Biotechniques 12 (1992) 82-87.
20. [20] S. Ye, S. Humphries, F. Green, Allele specific amplification by tetra-primer PCR, Nucleic Acids Res. 20 (1992) 1152.
21. [21] R.M. Myers, Z. Larin, T. Maniatis, Detection of single base substitutions by ribonuclease cleavage at mismatches in RNA:DNA dupexes, Science 230 (1985) 1242-1246.
22. [22] E. Winter, F. Yamamoto, C. Almoguera, M.A. Perucho, Methods to detect and characterize point mutations in transcribed genes: amplification and overexpression of the mutant c-Ki-ras allele in human tumor cells, Proc. Natl. Acad. Sci. USA 82 (1985) 7575-7579.
23. [23] V.C. Sheffield, D.R. Cox, D.R. Lerman, R.M. Myers, Attachment of a 40-base-pair G+C-rich sequence (GC-clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single-base changes, Proc. Natl. Acad. Sci. USA 86 (1989) 232-236.
24. [24] E.S. Abrams, S.E. Murdaugh, L.S. Lerman, Comprehensive detection of single base changes in hman genomic DNA using denaturing gradient gel electrophoresis and a GC clamp, Genomics 7 (1990) 463-475.
25. [25] M. Orita, Y. Suzuki, T. Sekiya, K. Hayashi, Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction, Genomics 5 (1989) 874-879.
26. [26] Y. Suzuki, M. Orita, M. Shiraishi, K. Hayashi, T. Sekiya, Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products, Oncogene 5 (1990) 1037-1043.
27. [27] Y. Kishimoto, Y. Murakami, M. Shiraishi, K. Hayashi, T. Sekiya, Aberrations of the p53 tumor suppressor gene in human non-small cell carcinomas of the lung, Cancer Res. 52 (1992) 4799-4804.
28. [28] R. Sachse, Y. Murakami, M. Shiraishi, K. Hayashi, T. Sekiya, DNA aberrations at the retinoblastoma gene locus in human squamous cell carcinomas of the lung, Oncogene 9 (1994) 39-47.
29. [29] K. Tamura, X. Zhang, Y. Murakami, S. Hirohashi, H.J. Xu, S.X. Hu, W.F. Benedict, T. Sekiya, Deletion of three distinct regions on chromosome 13q in human non-small cell lung cancer, Int. J. Cancer 74 (1997) 45-49.
30. [30] D.M. Valenzuela, J. Groffen, Four human carcinoma cell lines with novel mutations in position 12 of c-K-ras oncogene, Nucleic Acids Res. 14 (1986) 843-852.
31. [31] T.A. Lehman, W.P. Bennett, R.A. Metcalf, J.A. Welsh, J. Ecker, R.V. Modali, S. Ullrich, J.W. Romano, E. Appella, J.R. Testa et al., p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines, Cancer Res. 51 (1991) 4090-4096.
32. [32] G.I. Shapiro, J.E. Park, C.D. Edwards, L. Mao, A. Merlo, D. Sidransky, M.E. Ewen, B.J. Rollins, Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines, Cancer Res. 55 (1995) 6200-6209.
33. [33] R. Alemany, S. Ruan, M. Kataoka, P.E. Koch, T. Mukhopadhyay, R.J. Cristiano, Growth inhibitory effect of anti-K-ras adenovirus on lung cancer cells, Cancer Gene Ther. 3 (1996) 296-301.
34. [34] T. Mitsudomi, J. Viallet, J.L. Mulshine, R.I. Linnoila, J.D. Minna, A.F. Gazdar, Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines, Oncogene 6 (1991) 1353-1362.
35. [35] S.M. Bodner, J.D. Minna, S.M. Jensen, D. D'Amico, D. Carbone, T. Mitsudomi, J. Fedorko, D.L. Buchhagen, M.M. Nau, A.F. Gazdar et al., Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation, Oncogene 7 (1992) 743-749.
36. [36] A. Okamoto, D.J. Demetrick, E.A. Spillare, K. Hagiwara, S.P. Hussain, W.P. Bennett, K. Forrester, B. Gerwin, M. Serrano, D.H. Beach, C.C. Harris, Mutations and altered expression of p16INK4 in human cancer, Proc. Natl. Acad. Sci. USA 91 (1994) 11045-11049.
37. [37] R. Alemany, S. Ruan, M. Kataoka, P.E. Koch, T. Mukhopadhyay, R.J. Cristiano, J.A. Roth, W.W. Zhang, Growth inhibitory effect of anti-K-ras adenovirus on lung cancer cells, Cancer Gene Ther. 3 (1996) 296-301.
38. [38] T. Nobori, K. Miura, D.J. Wu, A. Lois, K. Takabayashi, D.A. Carson, Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers, Nature 368 (1994) 753-756.
39. [39] J.Y. Chen, W.D. Funk, W.E. Wright, J.W. Shay, J.D. Minna, Heterogeneity of transcriptional activity of mutant p53 proteins and p53 DNA target sequences, Oncogene 8 (1993) 2159-2166.
40. [40] M.S. Greenblatt, A.P. Grollman, C.C. Harri, Deletions and insertions in the p53 tumor suppressor gene in human cancers: confirmation of the DNA polymerase slippage/misalignment model, Cancer Res. 56 (1996) 2130-2136.
41. [41] M. Fukumoto, D.H. Shevrin, I.E. Roninson, Analysis of gene amplification in human tumor cell lines, Proc. Natl. Acad. Sci. USA 85 (1988) 6846-6850.
42. [42] K. Shimizu, D. Birnbaum, M.A. Ruley, O. Fasano, Y. Suard, L. Edlund, E. Taparowsky, M. Goldfarb, M. Wigler, Structure of the Ki-ras gene of the human lung carcinoma cell line Calu-1, Nature 304 (1983) 497-500.
43. [43] D.J. Capon, E.Y. Chen, A.D. Levinson, P.H. Seeburg, D.V. Goeddel, Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue, Nature 302 (1983) 33-37.
44. [44] M. Reiss, D.E. Brash, T. Munoz-Antonia, J.A. Simon, A. Ziegler, V.F. Vellucci, Z.L. Zhou, Status of the p53 tumor suppressor gene in human squamous carcinoma cell lines, Oncol. Res. 4 (1992) 349-357.
45. [45] M. Ramet, K. Castren, K. Jarvinen, K. Pekkala, T. Turpeenniemi-Hujanen, p53 protein expression is correlated with benzo[a]pyrene-DNA adducts in carcinoma cell lines, Carcinogenesis 16 (9) (1995) 2117-2124.
46. [46] A.J. Levine, J. Momand, C.A. Finlay, The p53 tumour suppressor gene, Nature 351 (1991) 453-456.
47. [47] Y. Taya, K. Hosogai, S. Hirohashi, Y. Shimosato, R. Tsuchiya, N. Tsuchida, M. Fushimi, T. Sekiya, S. Nishimura, A novel combination of K-ras and myc amplification accompanied by point mutational activation of K-ras in a human lung cancer, EMBO J. 3 (1984) 2943-2946.
48. [48] Y. Murakami, K. Hayashi, T. Sekiya, Detection of aberrations of the p53 alleles and the gene transcript in human tumor cell lines by single-strand conformation polymorphism analysis, Cancer Res. 51 (1991) 3356-3361.
49. [49] Y. Murakami, M. Katahira, R. Makino, K. Hayashi, S. Hirohashi, T. Sekiya, Inactivation of the retinoblastoma gene in a human lung carcinoma cell line detected by single-strand conformation polymorphism analysis of the polymerase chain reaction product of cDNA, Oncogene 6 (1991) 37-42.
50. [50] K. Yoshimoto, M. Shiraishi, S. Hirohashi, S. Morinaga, Y. Shimosato, T. Sugimura, T. Sekiya, Rearrangement of the c-myc gene in two giant cell carcinomas of the lung, Jpn. J. Cancer Res. 77 (1986) 731-735.
51. [51] M.A. Hawk, K.T. Cesen, J.C. Siglin, G.D. Stoner, R.J. Ruch, Inhibition of lung tumor cell growth in vitro and mouse lung tumor formation by lovastatin, Cancer Lett. 109 (1996) 217-222.
52. [52] Y. Murakami, Genetic alterations in human pancreatic cancer, J. Hepatol. Bil. Pancr. Surg. 4 (1997) 283-290.
53. [53] S. Nakamori, K. Yashima, Y. Murakami, O. Ishikawa, H. Ohigashi, S. Imaoka, S. Yaegashi, Y. Konishi, T. Sekiya, Association of p53 gene mutations with short survival in pancreatic adenocarcinoma, Jpn. J. Cancer Res. 86 (1995) 174-181.
54. [54] K. Yashima, S. Nakamori, Y. Murakami, A. Yamaguchi, K. Hayashi, O. Ishikawa, Y. Konishi, T. Sekiya, Mutations of the adenomatous polyposis coli gene in the mutation cluster region: comparison of human pancreatic and colorectal cancers, Int. J. Cancer 59 (1994) 43-47.
55. [55] T. Shimizu, W. Miwa, S. Nakamori, O. Ishikawa, Y. Konishi, T. Sekiya, Absence of a mutation of the p21 / WAF1 gene in human lung and pancreatic cancers, Jpn. J. Cancer Res. 87 (1996) 275-278.
56. [56] G. Berrozpe, J. Schaeffer, M.A. Peinado, F.X. Real, M. Perucho, Comparative analysis of mutations in the p53 and K-ras genes in pancreatic cancer, Int. J. Cancer 58 (1994) 185-191.
57. [57] M. Naumann, N. Savitskaia, C. Eilert, A. Schramm, H. Kalthoff, W. Schmiegel, Frequent codeletion of p16/MTS1 and p15/MTS2 and genetic alterations in p16/MTS1 in pancreatic tumors, Gastroenterology 110 (1996) 1215-1224.
58. [58] C. Caldas, S.A. Hahn, L.T. da Costa, M.S. Redston, M. Schutte, A.B. Seymour, C.L. Weinstein, R.H. Hruban, C.J. Yeo, S.E. Kern, Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma, Nat. Genet. 8 (1994) 27-32.
59. [59] L. Huang, T.L. Goodrow, S.Y. Zhang, A.J. Klein-Szanto, H. Chang, B.A. Ruggeri, Deletion and mutation analyses of the P16/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinomas, Cancer Res. 56 (1996) 1137-1141.
60. [60] M. Schutte, R.H. Hruban, L. Hedrick, K.R. Cho, G.M. Nadasdy, C.L. Weinstein, G.S. Bova, W.B. Isaacs, P. Cairns, H. Nawroz, D. Sidransky, R.A. Casero, P.S. Meltzer, S.A. Hahn, S.E. Kern, DPC4 gene in various tumor types, Cancer Res. 56 (1996) 2527-2530.
61. [61] B. Ruggeri, S.Y. Zhang, J. Caamano, M. DiRado, S.D. Flynn, A.J. Klein-Szanto, Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p53 and Rb-1 tumor-suppressor genes, Oncogene 7 (1992) 1503-1511.
62. [62] M. Goggins, M. Schutte, J. Lu, C.A. Moskaluk, C.L. Weinstein, G.M. Petersen, C.J. Yeo, C.E. Jackson, H.T. Lynch, R.H. Hruban, S.E. Kern, Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas, Cancer Res. 56 (1996) 5360-5364.
63. [63] Q. Liu, Y.X. Yan, M. McClure, H. Nakagawa, F. Fujimura, A.K. Rustgi, MTS-1 (CDKN2) tumor suppressor gene deletions are a frequent event in esophagus squamous cancer and pancreatic adenocarcinoma cell lines, Oncogene 10 (1995) 619-622.
64. [64] S.A. Hahn, M. Schutte, A.T. Hoque, C.A. Moskaluk, L.T. da Costa, E. Rozenblum, C.L. Weinstein, A. Fischer, C.J. Yeo, R.H. Hruban, S.E. Kern, DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1, Science 271 (1996) 350-353.
65. [65] H. Yamada, T. Yoshida, H. Sakamoto, M. Terada, T. Sugimura, Establishment of a human pancreatic adenocarcinoma cell line (PSN-1) with amplifications of both c-myc and activated c-Ki-ras by a point mutation, Biochem. Biophys. Res. Commun. 140 (1986) 167-173.
66. [66] Y. Murakami, K. Hayashi, S. Hirohashi, T. Sekiya, Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas, Cancer Res. 51 (1991) 5520-5525.
67. [67] X. Zhang, H.J. Xu, Y. Murakami, R. Sachse, K. Yashima, S. Hirohashi, S.X. Hu, W.F. Benedict, T. Sekiya, Deletions of chromosome 13q, mutations in retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma, Cancer Res. 54 (1994) 4177-4182.
68. [68] C.A. Richards, S.A. Short, S.S. Thorgeirsson, B.E. Huber BE, Characterization of a transforming N-ras gene in the human hepatoma cell line Hep G2: additional evidence for the importance of c-myc and ras cooperation in hepatocarcinogenesis, Cancer Res. 50 (1990) 1521-1527.
69. [69] I.C. Hsu, T. Tokiwa, W. Bennett, R.A. Metcalf, J.A. Welsh, T. Sun, C.C. Harris, p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines, Carcinogenesis 14 (1993) 987-992.
70. [70] B. Bressac, K.M. Galvin, T.J. Liang, K.J. Isselbacher, J.R. Wands, M. Ozturk, Abnormal structure and expression of p53 gene in human hepatocellular carcinoma, Proc. Natl. Acad. Sci. USA 87 (1990) 1973-1977.
71. [71] Y.J. Zhang, W. Jiang, C.J. Chen, C.S. Lee, S.M. Kahn, R.M. Santella, I.B. Weinstein, Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma, Biochem. Biophys. Res. Commun. 196 (1993) 1010-1016.
72. [72] M. Katahira, Y. Murakami, K. Hayashi, T. Sekiya, Detection of aberrations of the p53 gene but not the RB gene in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products, J. Tokyo Women Med. College 62 (1992) 206-213.
73. [73] J. He, J.R. Allen, V.P. Collins, M.J. Allalunis-Turner, R. Godbout, R.S. Day III, C.D. James, CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines, Cancer Res. 54 (1994) 5804-5807.
74. [74] C. Gomez-Manzano, J. Fueyo, A.P. Kyritsis, P.A. Steck, J.A. Roth, T.J. McDonnell, K.D. Steck, V.A. Levin, W.K. Yung, Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis, Cancer Res. 56 (1996) 694-699.
75. [75] J. Li, C. Yen, D. Liaw, K. Podsypanina, S. Bose, S.I. Wang, J. Puc, C. Miliaresis, L. Rodgers, R. McCombie, S.H. Bigner, B.C. Giovanella, M. Ittmann, B. Tycko, H. Hibshoosh, M.H. Wigler, R. Parsons, PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer, Science 275 (1997) 1943-1947.
76. [76] P.A. Steck, M.A. Pershouse, S.A. Jasser, W.K. Yung, H. Lin, A.M. Ligon, L.A. Langford, M.L. Baumgard, T. Hattier, T. Davis, C. Frye, R. Hu, B. Swedlund, D.H. Teng, S.V. Tavtigian, Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers, Nat. Genet. 15 (1997) 356-362.
77. [77] T. Ohtsubo, X. Wang, A. Takahashi, K. Ohnishi, H. Saito, C.W. Song, T. Ohnishi, p53-dependent induction of WAF1 by a low-pH culture condition in human glioblastoma cells, Cancer Res. 57 (1997) 3910-3913.
78. [78] J. Fueyo, C. Gomez-Manzano, W.K. Yung, G.L. Clayman, T.J. Liu, J. Bruner, V.A. Levin, A.P. Kyritsis, Adenovirus-mediated p16 / CDKN2 gene transfer induces growth arrest and modifies the transformed phenotype of glioma cells, Oncogene 12 (1996) 103-110.
79. [79] Y. Murakami, Y. Suzuki, Y. Kishimoto, S. Hirohashi, K. Hayashi, T. Sekiya, Detection of DNA aberrations in human cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products, Tohoku J. Exp. Med. 168 (1992) 247-255.
80. [80] T. Sekiya, Detection of mutant sequences by single-strand conformation polymorphism analysis, Mutat. Res. 288 (1993) 79-83.
81. [81] W. Miwa, J. Yasuda, K. Yashima, R. Makino, T. Sekiya, Absence of activating mutations of the RAF1 protooncogene in human lung cancer, Biol. Chem. Hoppe-Seyler 375 (1994) 705-709.
82. [82] T. Shimizu, T. Sekiya, Loss of heterozygosity at 9p21 loci and mutations of the MTS1 and MTS2 genes in human lung cancers, Int. J. Cancer 63 (1995) 616-620.
83. [83] R. Sachse, Y. Murakami, M. Shiraishi, K. Hayashi, T. Sekiya, Absence of activating mutations in the transmembrane domain of the c-erbB-2 protooncogene in human lung cancer, Jpn. J. Cancer Res. 83 (1992) 1299-1303.
84. [84] E. Rozenblum, M. Schutte, M. Goggins, S.A. Hahn, S. Panzer, M. Zahurak, S.N. Goodman, A. Taylor, R.H. Hruban, C.J. Yeo, S.E. Kern, Tumor-suppressive pathways in pancreatic carcinoma, Cancer Res. 57 (1997) 1731-1734.
85. [85] T. Sekiya, Y. Murakami, K. Hayashi, Detection of DNA aberrations in human cancers by single-strand conformation polymorphism analysis of the polymerase chain reaction, Int. J. Pancreatol. 13 (1993) 69-78.
86. [86] C. Almoguera, D. Shibata, K. Forrester, J. Martin, N. Arnheim, M. Perucho, Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes, Cell 53 (1988) 549-554.
87. [87] V.T. Smit, A.J. Boot, A.M. Smits, G.J. Fleuren, C.J. Cornelisse, J.L. Bos, KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas, Nucleic Acids Res. 16 (1988) 7773-7782.
88. [88] S.A. Hahn, M. Schutte, A.T. Hoque, C.A. Moskaluk, L.T. da Costa, E. Rozenblum, C.L. Weinstein, A. Fischer, C.J. Yeo, R.H. Hruban, S.E. Kern, A candidate tumor suppressor gene at human chromosome 18q21.1, Science 271 (1996) 350-353.
89. [89] K. Okada, Hepatocellular carcinoma: recent progress, Hepatology 15 (1992) 948-963.
90. [90] Y-J. Zhang, W. Jiang, C.J. Chen, Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma, Biochem. Biophys. Res. Commun. 196 (1993) 1010-1016.
91. [91] N. Nishida, Y. Fukuda, T. Komeda, Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma, Cancer Res. 54 (1994) 3107-3110.
92. [92] A.M. Hui, M. Sakamoto, Y. Kanai, Y. Ino, M. Gotoh, J. Yokota, S. Hirohashi S, Inactivation of p16INK4 in hepatocellular carcinoma, Hepatology 24 (1996) 575-579.
93. [93] H. Ueda, S.J. Ullrich, J.D. Gangemi, Functional inactivation but not structural mutation of p53 causes liver cancer, Nat. Genet. 9 (1995) 41-47.
94. [94] S. Mashiyama, Y. Murakami, T. Yoshimoto, T. Sekiya, K. Hayashi, Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products, Oncogene 6 (1991) 1313-1318.
95. [95] Y. Sonoda, T. Yoshimoto, T. Sekiya, Homozygous deletion of the MTS1 / p16 and MTS2 / p15 genes and amplification of the CDK4 gene in glioma, Oncogene 11 (1995) 2145-2149.
96. [96] Y. Sonoda, M. Iizuka, J. Yasuda, R. Makino, T. Ono, T. Kayama, T. Yoshimoto, T. Sekiya T, Loss of heterozygosity at 11p15 in malignant glioma, Cancer Res. 55 (1995) 2166-2168.
97. [97] Y. Sonoda, Y. Murakami, T. Tominaga, T. Kayama, T. Yoshimoto, T. Sekiya, Deletion mapping of chromosome 10 in human glioma, Jpn. J. Cancer Res. 87 (1996) 363-367.
98. [98] H. Kon, Y. Sonoda, T. Kumabe, T. Yoshimoto, T. Sekiya, Y. Murakami, Structural and functional evidence for the presence of tumor suppressor genes on the short arm of chromosome 10 in human gliomas, Oncogene 16 (1998) 257-263.
99. [99] S. Markowitz, J. Wang, L. Myeroff, R. Parsons, L. Sun, J. Lutterbaugh, R.S. Fan, E. Zborowska, K.W. Kinzler, B. Vogelstein, Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability, Science 268 (1995) 1336-1338.
100. [100] N. Rampino, H. Yamamoto, Y. Ionov, Y. Li, H. Sawai, J.C. Reed, M. Perucho M, Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype, Science 275 (1997) 967-969.
101. [101] R.M. Phelps, B.E. Johnson, D.C. Ihde, A.F. Gazdar, D.P. Carbone, P.R. McClintock, R.I. Linnoila, M.J. Matthews, P.A. Bunn Jr., D. Carney, J.D. Minna, J.L. Mulshine, NCI-Navy Medical Oncology Branch cell line data base, J. Cell. Biochem. Suppl. 24 (1996) 32-91.